Levels of serum ILD biomarkers such as KL-6 and SP-D, did not differ between the two groups (948.5 vs. 992.4 U/mL, P = 0.399; 190.0 vs. 172.7 ng/mL, P = 1.000). This evidence concerns the gene SFTPD and interstitial lung disease.